Immunological Studies to Understand Hybrid/Recombinant Variants of SARS-CoV-2

Abstract

The zoonotic SARS-CoV-2 virus was present before the onset of the pandemic. It undergoes evolution, adaptation, and selection to develop variants that gain high transmission rates and virulence, resulting in the pandemic. Structurally, the spike protein of the virus is required for binding to ACE2 receptors of the host cells. The gene coding for the spike is known to have a high propensity of mutations, as a result generating numerous variants. The variants can be generated by random point mutations or recombination during replication. However, SARS-CoV-2 can also produce hybrid variants on co-infection of the host by two distinct lineages of the virus. The genomic sequences of the two variants undergo recombination to produce the hybrid variants. Additionally, these sub-variants also contain numerous mutations from both the parent variants, as well as some novel mutations unique to the hybrids. The hybrid variants (XD, XE, and XF) can be identified through numerous techniques, such as peak PCR, NAAT, and hybrid capture SARS-CoV-2 NGS (next generation sequencing) assay, etc., but the most accurate approach is genome sequencing. There are numerous immunological diagnostic assays, such as ELISA, chemiluminescence immunoassay, flow-cytometry-based approaches, electrochemiluminescence immunoassays, neutralization assays, etc., that are also designed and developed to provide an understanding of the hybrid variants, their pathogenesis, and other reactions. The objective of our study is to comprehensively analyze the variants of SARS-CoV-2, especially the hybrid variants. We have also discussed the techniques available for the identification of hybrids, as well as the immunological assays and studies for analyzing the hybrid variants.

Unraveling the Dynamics of Omicron (BA.1, BA.2, and BA.5) Waves and Emergence of the Deltacron Variant: Genomic Epidemiology of the SARS-CoV-2 Epidemic in Cyprus (Oct 2021–Oct 2022)

“…XD, for instance, showcased the Omicron spike protein mutations in conjunction with a Delta backbone. In other instances, breakpoints within the ORF1ab region were observed, with the remainder of the genome reflecting Omicron characteristics [ 77 , 78 , 79 , 80 , 81 , 82 , 83 , 84 , 85 , 86 , 87 , 88 , 89 , 90 , 91 ]. These discoveries garnered considerable attention and were subsequently monitored by the World Health Organization (WHO).…”

“…These discoveries garnered considerable attention and were subsequently monitored by the World Health Organization (WHO). Comprehensive investigations were launched to ascertain the potential risks posed by these recombinants and to evaluate the effectiveness of existing vaccines in addressing them [ 55 , 80 , 88 , 89 , 91 ].…”

Regulatory T Cells (Tregs) and COVID-19: Unveiling the Mechanisms, and Therapeutic Potentialities with a Special Focus on Long COVID

“…Numerous researchers hold the view that adaptive immune responses, particularly cell-mediated immune responses, are essential for limiting the SARS-CoV-2 infection by regulating the release of essential cytokines and other anti-inflammatory proteins [ 6 ]. Furthermore, the rapid evolution of SARS-CoV-2 into the diverge variants with a plethora of mutations makes scientists think about the cell-mediated immune response seriously [ 7 , 8 ].…”

Phytochemical-loaded Nanoparticles in COVID-19 Management

“…It is also 96.3% identical to the horseshoe bat coronavirus and 82% identical to the human SARS coronavirus 1. The virus undergoes rapid mutations resulting in the emergence of numerous variants which are further classified into variants of concern (VOC), variants of interest (VOI), variants being monitored (VBM), and variants of high consequences (VOHC) (Chavda et al, 2022).…”